Legacy Citation Support
21 U.S.C. § 356c-1
This citation is not available as a current section page in the published edition on this site, but the citation remains a meaningful historical or legacy reference.
Use the current title page and nearby sections below to continue browsing Title 21. When old citations remain in crawlers, briefs, or legacy links, this page preserves the citation locally instead of sending users to a dead end.
Nearby current sections
- § 356 — Expedited approval of drugs for serious or life-threatening diseases or conditions
- § 356a — Manufacturing changes
- § 356b — Reports of postmarketing studies
- § 356c — Discontinuance or interruption in the production of life-saving drugs
- § 356c–1 — Annual reporting on drug shortages
- § 356d — Coordination; task force and strategic plan
- § 356e — Drug shortage list
- § 356f — Hospital repackaging of drugs in shortage